Chamorro Clara Ibel, Zeiai Said, Engberg Gisela Reinfeldt, Brodin David, Nordenskjöld Agneta, Fossum Magdalena
1 Department of Women's and Children's Health, Centre for Molecular Medicine , Karolinska Institutet, Stockholm, Sweden .
Tissue Eng Part A. 2015 Feb;21(3-4):510-7. doi: 10.1089/ten.TEA.2014.0175. Epub 2014 Oct 3.
Cultured human urothelial cells can be used in tissue engineering for reconstruction of urothelial defects. For safety reasons, a fine characterization of the cells is required before use in reconstructive surgery. For these reasons, we aimed to characterize the effect of in vitro propagation of urothelial cells on gene expression and proliferative capacity. Gene expression of urothelial cells in passage two and eight was captured by using a microarray chip covering the whole human genome. To find relationships in biological functions and pathways, differentially regulated genes were subjected to pathway analysis using the WEB-based Gene Set Analysis Toolkit (WebGestalt). Proliferative capacity was tested with population doubling time, efficiency in colony formation assays, and immunocytochemistry. In addition, senescence markers were evaluated. Bioinformatics analysis revealed gene expression profile differences. Downregulated genes at passage eight clustered in biological pathways of cell cycle and DNA repair processes; upregulated genes had no obvious association to any specific biological function or pathway according to WebGestalt analysis, but individual genes with extracellular matrix, apoptosis, and cell morphology. Data were supported by reverse transcription-polymerase chain reaction (RT-PCR) and in vitro growth experiments. Passage two urothelial cells had higher efficiency in colony formation and lower population doubling time. An increase in senescence markers was detected at passage eight. We conclude that pretransplantation quality controls are important and, for reconstructive purposes, cells should be transplanted back to the patient as soon as possible to procure good proliferative capacity also after transplantation.
培养的人尿道上皮细胞可用于组织工程,以重建尿道上皮缺损。出于安全考虑,在用于重建手术之前,需要对细胞进行精细表征。基于这些原因,我们旨在表征尿道上皮细胞体外传代对基因表达和增殖能力的影响。使用覆盖整个人类基因组的微阵列芯片捕获第二代和第八代尿道上皮细胞的基因表达。为了找到生物学功能和途径之间的关系,使用基于网络的基因集分析工具包(WebGestalt)对差异调节基因进行途径分析。通过群体倍增时间、集落形成试验效率和免疫细胞化学来测试增殖能力。此外,还评估了衰老标志物。生物信息学分析揭示了基因表达谱差异。第八代下调的基因聚集在细胞周期和DNA修复过程的生物学途径中;根据WebGestalt分析,上调的基因与任何特定的生物学功能或途径没有明显关联,但个别基因与细胞外基质、细胞凋亡和细胞形态有关。数据得到逆转录-聚合酶链反应(RT-PCR)和体外生长实验的支持。第二代尿道上皮细胞集落形成效率更高,群体倍增时间更短。在第八代检测到衰老标志物增加。我们得出结论,移植前的质量控制很重要,出于重建目的,细胞应尽快移植回患者体内,以便在移植后也能获得良好的增殖能力。